Skip to content

Efectiveness of dydrogesterone and progesterone in prevention of preterm birth in women with a short cervix

Effectiveness of Dydrogesterone and Progesterone in prevention of preterm birth in women with a short cervix

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221107056426N1
Enrollment
64
Registered
2022-11-14
Start date
2022-11-08
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm labour. Preterm labor

Interventions

Intervention 1: Intervention group: Vaginal progesterone group, daily one suppository of 400 mg of vaginal progesterone suppository and three oral pills of the same placebo (vitamin B6). Intervention

Sponsors

Gorgan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Cervical length less than 25 mm, measured by transvaginal ultrasound Singleton pregnancy Refer to the center at the age of pregnancy between 6 and 18 weeks Any evidence of threatened abortion( vaginal bleeding and bloody vaginal discharge) in the first half of pregnancy Willingness and written consent to enter the study Follow-up and regular referrals for pregnancy care

Exclusion criteria

Exclusion criteria: Multiple pregnancy Any uncontrolled systemic disease(diabete, blood pressure, kidney, liver, etc.) History of consuming alcoholic beverages or drug or drug abuse Absence of gestational sac in the fifth week Lack of yolk sac in 5.5 to 6 weeks of pregnancy Absence of fetus in 6-6.5 weeks of pregnancy Absence of fetal heartbeat in weeks 16 to 24 Having a history of preterm delivery Having a pair of umbilical cords confirmed by transvaginal ultrasound History of surgery on the cervix Fetal and uterine anomalies

Design outcomes

Primary

MeasureTime frame
Cervical length. Timepoint: 1, 5, 9 weeks after starting treatment and immediately after delivery. Method of measurement: Vaginal ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahboobeh Khajehpour

Gorgan University of Medical Sciences

Mahboobkhajepour@gmail.com0098 43 32131722

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026